Similar Articles
731 Mechanisms of hepatocellular carcinoma progression
732 Change in arterial tumor perfusion is an early biomarker of lenvatinib efficacy in patients with unresectable hepatocellular carcinoma
733 Stereotactic body radiation therapy in patients with hepatocellular carcinoma: A mini-review
734 ADAMTS13 and von Willebrand factor are useful biomarkers for sorafenib treatment efficiency in patients with hepatocellular carcinoma
735 Role and mechanism of circ-PRKCI in hepatocellular carcinoma
736 Dual energy computed tomography for detection of metastatic lymph nodes in patients with hepatocellular carcinoma
737 MicroRNAs contribute to ATP-binding cassette transporter- and autophagy-mediated chemoresistance in hepatocellular carcinoma
738 Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value
739 Validated model for prediction of recurrent hepatocellular carcinoma after liver transplantation in Asian population
740 Update on hepatocellular carcinoma: Pathologists’ review
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA